SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Mar-21 7:41 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 11,875 | -- | -- | 68% 17.42K to 29.3K | |
13-Mar-20 5:40 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 05-Mar-20 | Grant | 1,500 | $7.31 | $10,965.00 | 10% 14.42K to 15.92K | |
06-Sep-19 6:37 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 05-Sep-19 | Grant | 1,500 | $7.95 | $11,921.20 | 12% 12.92K to 14.42K | |
26-Mar-19 10:12 AM View: | Eiger BioPharmaceuticals, I... (EIGR) | 05-Mar-19 | Grant | 1,500 | $7.95 | $11,921.20 | 13% 11.42K to 12.92K | |
26-Mar-19 10:12 AM View: | Eiger BioPharmaceuticals, I... (EIGR) | 05-Sep-18 | Grant | 1,500 | $7.95 | $11,921.20 | 15% 9.92K to 11.42K | |
26-Mar-19 10:12 AM View: | Eiger BioPharmaceuticals, I... (EIGR) | 05-Mar-18 | Grant | 1,500 | $8.03 | $12,048.80 | 18% 8.42K to 9.92K | |
26-Mar-19 10:12 AM View: | Eiger BioPharmaceuticals, I... (EIGR) | 05-Sep-17 | Grant | 1,500 | $9.90 | $14,853.80 | 22% 6.92K to 8.42K | 2% |
26-Mar-19 10:12 AM View: | Eiger BioPharmaceuticals, I... (EIGR) | 06-Mar-17 | Grant | 1,301 | $8.20 | $10,671.50 | 23% 5.62K to 6.92K | |
19-Aug-16 10:00 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 18-Aug-16 | Market Purchase | 3,125 | $15.70 | $49,062.50 | 125% 2.5K to 5.62K | (37%) |
14-Jun-16 6:45 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 13-Jun-16 | Market Purchase | 1,250 | $22.17 | $27,717.80 | 100% 1.25K to 2.5K | (55%) |
23-May-16 6:37 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 23-May-16 | Market Purchase | 745 | $19.99 | $14,892.50 | 149% 0.5K to 1.25K | (50%) |
23-May-16 6:37 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 19-May-16 | Market Purchase | 500 | $19.52 | $9,760.00 | 100% 0 to 0.5K | (49%) |
04-Feb-14 9:05 PM View: | Halozyme Therapeutics, Inc. (HALO) | 04-Feb-14 | Option Exercise | 4,864 | -- | -- | 10% 49.16K to 54.02K | |
04-Feb-14 9:05 PM View: | Halozyme Therapeutics, Inc. (HALO) | 02-Feb-14 | Option Exercise | 11,629 | -- | -- | 31% 37.53K to 49.16K | |
05-Feb-13 8:21 PM View: | Halozyme Therapeutics, Inc. (HALO) | 02-Feb-13 | Option Exercise | 11,232 | -- | -- | 43% 26.3K to 37.53K | |
14-Nov-12 7:06 PM View: | Halozyme Therapeutics, Inc. (HALO) | 14-Nov-12 | Market Purchase | 20,000 | $5.22 | $104,400.00 | 317% 6.3K to 26.3K | |
14-Apr-11 3:33 PM View: | Clinical Data, Inc. (CLDA) | 12-Apr-11 | Disposition (change in control) | 1,000 | $30.00 | $30,000.00 | (100%) 1.0K to 0 | (3%) |